Clinical Trials Logo

Clinical Trial Summary

The main objective of this study is to evaluate efficacy and safety of ALS-L1023 tablet in patients with abdominal obesity of metabolic syndrome.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01872182
Study type Interventional
Source Hanmi Pharmaceutical Company Limited
Contact
Status Terminated
Phase Phase 3
Start date May 2013
Completion date January 2015

See also
  Status Clinical Trial Phase
Terminated NCT01887119 - Aldosterone Antagonism and Microvascular Function Phase 4
Completed NCT02954588 - Effect of Pyridoxamine Supplementation on Vascular Function and Insulin Sensitivity N/A
Completed NCT02283242 - Galantamine Effects in Patients With Metabolic Syndrome Phase 4
Completed NCT03020186 - Effects of Green-MED Diet Via the Gut-fat-brain Axis N/A
Completed NCT02353767 - Evaluation of Liver Fibrosis in HIV-infected Patients With Metabolic Syndrome N/A
Recruiting NCT02001376 - A Health Promotion Project for Workers at National Taiwan University Hospital N/A